NO20083876L - Doseformer for administrering av combinasjonsmedikamenter - Google Patents
Doseformer for administrering av combinasjonsmedikamenterInfo
- Publication number
- NO20083876L NO20083876L NO20083876A NO20083876A NO20083876L NO 20083876 L NO20083876 L NO 20083876L NO 20083876 A NO20083876 A NO 20083876A NO 20083876 A NO20083876 A NO 20083876A NO 20083876 L NO20083876 L NO 20083876L
- Authority
- NO
- Norway
- Prior art keywords
- dosage forms
- administration
- combination
- absorption
- drugs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77937306P | 2006-03-06 | 2006-03-06 | |
PCT/US2007/005266 WO2007103113A2 (en) | 2006-03-06 | 2007-03-02 | Dosage forms for administering combinations of drugs |
US11/712,969 US20070207200A1 (en) | 2006-03-06 | 2007-03-02 | Dosage forms for administering combinations of drugs |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083876L true NO20083876L (no) | 2008-12-02 |
Family
ID=38471739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083876A NO20083876L (no) | 2006-03-06 | 2008-09-10 | Doseformer for administrering av combinasjonsmedikamenter |
Country Status (13)
Country | Link |
---|---|
US (1) | US20070207200A1 (de) |
EP (1) | EP1993518A4 (de) |
JP (1) | JP5349059B2 (de) |
CN (1) | CN101410095B (de) |
AU (1) | AU2007224229B2 (de) |
BR (1) | BRPI0708640A8 (de) |
CA (1) | CA2644435C (de) |
EA (1) | EA020867B1 (de) |
HK (1) | HK1128230A1 (de) |
IL (1) | IL193727A (de) |
MX (1) | MX2008011441A (de) |
NO (1) | NO20083876L (de) |
WO (1) | WO2007103113A2 (de) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US20060178349A1 (en) * | 2005-01-24 | 2006-08-10 | Pozen Inc. | Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID |
US8795721B2 (en) * | 2006-12-18 | 2014-08-05 | Eatlittle Inc. | Device for delivery of a substance |
GB0625646D0 (en) * | 2006-12-21 | 2007-01-31 | Jagotec Ag | Improvements in or relating to organic compounds |
BRPI0700133A (pt) * | 2007-01-29 | 2008-09-16 | Incrementha P D & I Pesquisa D | composição farmacêutica compreendendo tramadol e cetoprofeno em combinação |
US20090068262A1 (en) * | 2007-04-04 | 2009-03-12 | Ilan Zalit | Rapid dissolution of combination products |
CA2690829A1 (en) * | 2007-07-20 | 2009-01-29 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
GB0714790D0 (en) * | 2007-07-30 | 2007-09-12 | Jagotec Ag | Improvements in or relating to organic compounds |
BRPI0818762B8 (pt) * | 2007-10-16 | 2021-05-25 | Chimigen Inc | composição farmacêutica bicamada de liberação imediata e controlada contendo tramadol e acetaminofeno, e, uso de uma composição |
ATE455538T1 (de) * | 2007-11-09 | 2010-02-15 | Acino Pharma Ag | Retardtabletten mit hydromorphon |
US20090186086A1 (en) * | 2008-01-17 | 2009-07-23 | Par Pharmaceutical, Inc. | Solid multilayer oral dosage forms |
US9226907B2 (en) | 2008-02-01 | 2016-01-05 | Abbvie Inc. | Extended release hydrocodone acetaminophen and related methods and uses thereof |
US8372432B2 (en) | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
AU2009223061B2 (en) | 2008-03-11 | 2014-10-09 | Depomed Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
US20090252791A1 (en) * | 2008-04-02 | 2009-10-08 | Venkata Nookaraju Sreedharala | Pharmaceutical compositions comprising a triptan and a nonsteroidal anti-inflammatory drug |
AU2013202680C1 (en) * | 2008-04-28 | 2016-06-23 | Zogenix, Inc. | Novel formulations for treatment of migraine |
JP2011518881A (ja) * | 2008-04-28 | 2011-06-30 | ゾゲニクス インコーポレーティッド | 片頭痛の治療のための製剤 |
WO2009152551A1 (en) * | 2008-06-20 | 2009-12-23 | Alphapharm Pty Ltd | Pharmaceutical formulation |
US20100008986A1 (en) * | 2008-07-14 | 2010-01-14 | Glenmark Generics, Ltd. | Pharmaceutical compositions comprising sumatriptan and naproxen |
MX2011002515A (es) | 2008-09-09 | 2011-04-07 | Astrazeneca Ab | Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita. |
MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
US20110150989A1 (en) * | 2009-12-22 | 2011-06-23 | Mallinkckrodt Inc. | Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans |
WO2011087765A2 (en) * | 2009-12-22 | 2011-07-21 | Mallinckrodt Inc. | Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
US20120015031A1 (en) * | 2010-07-14 | 2012-01-19 | Grunenthal Gmbh | Novel gastro-retentive dosage forms |
CN101987092A (zh) * | 2010-09-27 | 2011-03-23 | 苏州世林医药技术发展有限公司 | 含有镇痛剂的新型药学组成物 |
US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
US10525054B2 (en) | 2011-11-07 | 2020-01-07 | Inheris Biopharma, Inc. | Compositions, dosage forms, and co-administration of an opioid agonist compound and an analgesic compound |
US9457024B2 (en) | 2011-11-07 | 2016-10-04 | Nektar Therapeutics | Compositions, dosage forms, and co-administration of an opioid agonist compound and a non-steroidal anti-inflammatory drug |
BR112014016085A8 (pt) | 2011-12-28 | 2017-07-04 | Pozen Inc | composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico |
CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
MX2013008995A (es) * | 2013-08-02 | 2014-03-24 | Raam De Sahuayo S A De C V Lab | Composicion farmaceutica para el tratamiento del dolor. |
MX362435B (es) * | 2013-08-02 | 2019-01-17 | Laboratorio Raam De Sahuayo S A De C V | Novedoso sistema farmaceutico de entrega bifasica para el tratamiento del dolor y la inflamacion. |
CA2919892C (en) | 2013-08-12 | 2019-06-18 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
CN104434918A (zh) * | 2013-09-16 | 2015-03-25 | 江苏恩华药业股份有限公司 | 盐酸羟考酮与布洛芬复方多层片及其制备方法 |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US20150209360A1 (en) * | 2014-01-30 | 2015-07-30 | Orbz, Llc | Oral caffeine delivery composition |
EP3169315B1 (de) | 2014-07-17 | 2020-06-24 | Pharmaceutical Manufacturing Research Services, Inc. | Missbrauchssichere flüssigkeitsfülldosierform mit unmittelbarer freisetzung |
JP6672277B2 (ja) * | 2014-10-08 | 2020-04-01 | シンセティック・バイオロジクス・インコーポレイテッド | ベータラクタマーゼ製剤およびその使用 |
WO2016064873A1 (en) | 2014-10-20 | 2016-04-28 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
CN104523709A (zh) * | 2014-12-22 | 2015-04-22 | 青岛正大海尔制药有限公司 | 一种含有琥珀酸夫罗曲坦的复方缓释制剂 |
KR101710792B1 (ko) * | 2015-07-14 | 2017-02-28 | 주식회사 유영제약 | 세레콕시브 및 트라마돌을 함유하는 약제학적 조성물 |
CN109700816B (zh) * | 2018-12-29 | 2020-10-16 | 南通励成生物工程有限公司 | 磷脂酰丝氨酸肠溶包衣制剂及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
EP0546593B1 (de) * | 1991-10-30 | 1997-09-03 | Glaxo Group Limited | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
GB9407386D0 (en) * | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
DE19601477C2 (de) * | 1996-01-17 | 1999-12-16 | Axel Kirsch | Befestigungsnagel |
US6077539A (en) * | 1996-11-12 | 2000-06-20 | Pozen, Inc. | Treatment of migraine headache |
DE19710008A1 (de) * | 1997-03-12 | 1998-09-17 | Basf Ag | Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung |
DE69819351D1 (de) * | 1997-09-11 | 2003-12-04 | Nycomed Danmark As Roskilde | Aus mehreren einzeleinheiten zusammengesetzte arzneimittel mit nicht-steroidalen wirkstoffen (nsaids) |
DE19901687B4 (de) * | 1999-01-18 | 2006-06-01 | Grünenthal GmbH | Opioide Analgetika mit kontrollierter Wirkstofffreisetzung |
JP2006506461A (ja) * | 2002-10-25 | 2006-02-23 | コルジウム ファーマシューティカル, インコーポレイテッド | ミルナシプランのパルス型放出組成物 |
US7332183B2 (en) * | 2002-12-26 | 2008-02-19 | Pozen Inc. | Multilayer dosage forms containing NSAIDs and triptans |
AU2004247076A1 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and NSAIDs |
US8263126B2 (en) * | 2003-06-06 | 2012-09-11 | Ethypharm | Orally-dispersible multilayer tablet |
FR2855756B1 (fr) * | 2003-06-06 | 2005-08-26 | Ethypharm Sa | Comprime orodispersible multicouche |
KR20070036797A (ko) * | 2004-07-26 | 2007-04-03 | 테바 파마슈티컬 인더스트리즈 리미티드 | 장용 코팅된 중심정을 갖는 제형 |
-
2007
- 2007-03-02 MX MX2008011441A patent/MX2008011441A/es active IP Right Grant
- 2007-03-02 WO PCT/US2007/005266 patent/WO2007103113A2/en active Application Filing
- 2007-03-02 CN CN200780011121.4A patent/CN101410095B/zh not_active Expired - Fee Related
- 2007-03-02 AU AU2007224229A patent/AU2007224229B2/en not_active Ceased
- 2007-03-02 BR BRPI0708640A patent/BRPI0708640A8/pt not_active Application Discontinuation
- 2007-03-02 US US11/712,969 patent/US20070207200A1/en not_active Abandoned
- 2007-03-02 CA CA2644435A patent/CA2644435C/en not_active Expired - Fee Related
- 2007-03-02 EA EA200870325A patent/EA020867B1/ru not_active IP Right Cessation
- 2007-03-02 JP JP2008558308A patent/JP5349059B2/ja not_active Expired - Fee Related
- 2007-03-02 EP EP07751994A patent/EP1993518A4/de not_active Withdrawn
-
2008
- 2008-08-27 IL IL193727A patent/IL193727A/en not_active IP Right Cessation
- 2008-09-10 NO NO20083876A patent/NO20083876L/no not_active Application Discontinuation
-
2009
- 2009-07-03 HK HK09105987.5A patent/HK1128230A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2009539761A (ja) | 2009-11-19 |
EA020867B1 (ru) | 2015-02-27 |
AU2007224229A1 (en) | 2007-09-13 |
WO2007103113A2 (en) | 2007-09-13 |
IL193727A (en) | 2015-07-30 |
CN101410095B (zh) | 2015-07-01 |
JP5349059B2 (ja) | 2013-11-20 |
IL193727A0 (en) | 2009-05-04 |
EP1993518A4 (de) | 2012-12-12 |
WO2007103113A3 (en) | 2007-11-01 |
US20070207200A1 (en) | 2007-09-06 |
CA2644435A1 (en) | 2007-09-13 |
AU2007224229B2 (en) | 2012-10-11 |
CN101410095A (zh) | 2009-04-15 |
MX2008011441A (es) | 2008-11-18 |
HK1128230A1 (en) | 2009-10-23 |
CA2644435C (en) | 2015-04-07 |
BRPI0708640A2 (pt) | 2011-06-07 |
EP1993518A2 (de) | 2008-11-26 |
EA200870325A1 (ru) | 2009-02-27 |
BRPI0708640A8 (pt) | 2018-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083876L (no) | Doseformer for administrering av combinasjonsmedikamenter | |
Viscusi et al. | Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability | |
EP2444072A3 (de) | Nichtmukoadhäsive Filmdosierungsformen | |
ECSP17013617A (es) | combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid | |
WO2006069293A3 (en) | Composition comprising n-acetylcysteine and further pain or anti- inflamm medications | |
WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
WO2003057170A3 (en) | Oral insulin therapy | |
MX2009005339A (es) | Suspensiones analgesicas de liberacion modificada. | |
RU2007132181A (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ | |
AR052052A1 (es) | Terapia de combinacion | |
BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
NO20075393L (no) | Akarbosebaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse | |
NO20080244L (no) | Doseringsstyring for prasugrel | |
AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
CN100569269C (zh) | 止痛药 | |
WO2006124573A3 (en) | Treatment of cancer with 2-deoxyglucose | |
Moffa et al. | Bromelain after oral or dental procedures: an update | |
WO2008079818A3 (en) | Intravenous administration of water soluble analgesic formulations | |
JP2013523844A5 (de) | ||
RU2008103666A (ru) | Способ лечения острой аллергии и устройство для доставки лекарственного средства | |
Wyndaele et al. | MP-05.02 Combination Therapy with Tamsulosin OCAS™ and Solifenacin is more Effective than Solifenacin Monotherapy as a Treatment for Male LUTS Associated with BPH: Results from the SATURN Trial | |
PIÑA | Supra-additive interaction of docosahexaenoic acid and naproxen and gastric safety on the formalin test in rats | |
Huffman | Loratadine and fluticasone nasal spray: Added benefit? | |
JP2008214331A (ja) | ピンポイント注射りょう法 | |
Schmidt | (381) Evaluation of headache pain response and nausea relief relative to triptan use and placebo in migraine patients treated with diclofenac potassium for oral solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |